Activist investor Elliott threatens Southwest Airlines proxy fight for leadership changes
Adds Southwest's comments in paragraph 5
By Rajesh Kumar Singh and Shivansh Tiwary
July 8 (Reuters) -Activist investor Elliott Investment Management on Monday warned of a proxy fight to push for leadership changes at U.S. budget carrier Southwest Airlines LUV.N.
In a letter to Southwest's board, Elliott said while it is open to collaboration, it plans to "move expeditiously to give shareholders a direct say on the necessary leadership changes."
The investment management firm, known for pushing changes to boost shareholder returns, has called for a reconstitution of Southwest's board with "new, truly independent" directors possessing expertise in airlines, customer experience and technology.
Ithas also called for a leadership change citing Southwest's disappointing financial results.
In a statement, Southwest said it remains open to constructive conversations with Elliott, including evaluating additional "strong and independent" director candidates. The airline, however, added the investment firm has focused on personal attacks on its leadership and board, conditioning any serious discussions on an immediate CEO change.
In its letter, Elliott said the airline's performance is "unacceptable" and a leadership change is required to return it to its once-leading position in the industry.
"Shareholders simply do not believe this board and management team are capable of devising and executing a bold new plan to turn around Southwest," it said.
Elliott currently owns an 11% stake in the company, making it one of the largest investors.
Last week, Southwest said the activist investor had made filings with antitrust authorities that would allow it to acquire an even larger voting power as early as July 11. It prompted the company to adopt a "poison pill", used by corporate boards to thwart hostile takeover bids, to deter Elliott from raising its stake.
Elliott said it is not seeking control of Southwest, but added the airline's board has put its own "self-interest ahead of the company's" by adopting the "poison pill."
It also criticized the appointment of aviation industry veteran Rakesh Gangwal to Southwest's board, calling it an attempt on the part of the board to "entrench itself and the current management team."
"These actions...demonstrate how profoundly out of touch Southwest's board has become with shareholder sentiment and with the reality of the situation," Elliott said in its letter.
Gangwal - who co-founded InterGlobe Aviation INGL.NS, the operator of India's largest airline IndiGo - has also served on the boards of US Airways Group, CarMax KMX.N and Office Depot, among others.
"Rakesh's expertise in travel technology will be valuable as we continue to make investments that support our operations and strategic initiatives," said Gary Kelly, executive chairman of Southwest's board.
Reporting by Rajesh Kumar Singh in Chicago and Shivansh Tiwary in Bengaluru; Editing by Shilpi Majumdar, Anil D'Silva and Josie Kao
Mga Kaugnay na Asset
Pinakabagong Balita
Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.
Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.
Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.
